Tacrolimus dosing in Chinese renal transplant recipients: a population-based pharmacogenetics study (Q83435750)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Tacrolimus dosing in Chinese renal transplant recipients: a population-based pharmacogenetics study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Liang Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Chuan-Jiang Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lei Zheng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yan-Jun Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hai-Xia Jiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Bo Si-Tu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Zhong-Hai Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

18 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

787-795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-011-1010-y

22 January 2020

exact match

0 references

cites work

Genetic variability in CYP3A5 and its possible consequences.

1 reference

12 December 2020

Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors

1 reference

12 December 2020

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

1 reference

12 December 2020

Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

1 reference

12 December 2020

Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects

1 reference

12 December 2020

Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects

1 reference

12 December 2020

Stepwise regression analysis of the determinants of blood tacrolimus concentrations in Chinese patients with liver transplant.

1 reference

12 December 2020

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

1 reference

12 December 2020

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference

1 reference

12 December 2020

Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group

1 reference

12 December 2020

Optimization of initial tacrolimus dose using pharmacogenetic testing

1 reference

12 December 2020

Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients.

1 reference

12 December 2020

Reduced exposure to calcineurin inhibitors in renal transplantation

1 reference

12 December 2020

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients

1 reference

12 December 2020

Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor

1 reference

12 December 2020

Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients

1 reference

12 December 2020

The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?

1 reference

12 December 2020

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

1 reference

12 December 2020

Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients

1 reference

12 December 2020

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

1 reference

12 December 2020

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.

1 reference

12 December 2020

Factors affecting the long-term response to tacrolimus in renal transplant patients: pharmacokinetic and pharmacogenetic approach

1 reference

12 December 2020

P-glycoprotein: from genomics to mechanism.

1 reference

12 December 2020

MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.

1 reference

12 December 2020

Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety

1 reference

12 December 2020

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

12 December 2020

The role of ABC transporters in protecting cells from bilirubin toxicity

1 reference

12 December 2020

A limited sampling strategy for tacrolimus in renal transplant patients

1 reference

12 December 2020

Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients

1 reference

12 December 2020

Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements

1 reference

12 December 2020

10.1007/S00228-011-1010-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331500%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference